PMVP Stock Summary and Trading Ideas (PMV Pharmaceuticals | NASDAQ:PMVP)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

PMV Pharmaceuticals trades on the NASDAQ stock market under the symbol PMVP.

As of January 2, 2026, PMVP stock price declined to $1.23 with 106,000 million shares trading.

PMVP has a beta of 0.32, meaning it tends to be less sensitive to market movements. PMVP has a correlation of 0.01 to the broad based SPY ETF.

PMVP has a market cap of $65.45 million. This is considered a Micro Cap stock.

In the last 3 years, PMVP traded as high as $9.72 and as low as $.81.

The top ETF exchange traded funds that PMVP belongs to (by Net Assets): VTI, VXF, IWC.

PMVP has underperformed the market in the last year with a return of -18.5%, while the SPY ETF gained +17.8%. In the last 3 month period, PMVP fell short of the market, returning -12.1%, while SPY returned +2.8%. However, in the most recent 2 weeks PMVP has outperformed the stock market by returning +8.8%, while SPY returned +2.0%.

PMVP support price is $1.20 and resistance is $1.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PMVP shares will trade within this expected range on the day.